A comprehensive view of GlobalData Plc. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

GlobalData: Eli Lilly set to reshape pharmaceutical landscape with obesity and Alzheimer's treatments, Mounjaro and donanemab; both drugs poised to beat market expectations, with Mounjaro's sales poised to reach US$34B in 2029, more than double Wegovy's
Published: April 17, 2024 by GlobalData Plc
GlobalData predicts GLP-1 drugs will redefine big pharma sales; Eli Lilly's diabetes drug, Mounjaro, is forecasted to generate US$34.0B by 2029, surpassing the entire 2023 portfolio of Lilly, with the Alzheimer's drug donanemab adding another US$5.0B
Published: April 17, 2024 by FiercePharma
GlobalData: US obesity drug market set for surge with 13 new launches projected over next five years; Novo Nordisk to lead with six launches, including Cagrisema that's expected to launch in 2025 and generate US$7.4B by 2029
Published: April 16, 2024 by Outsourcing-Pharma.com
GlobalData: Robotics reshape automotive manufacturing, boosting automation, driving efficiency and optimizing development of autonomous vehicles; challenges include job displacement, regulatory uncertainties over autonomous vehicles
Published: April 15, 2024 by GlobalData Plc
GlobalData forecasts India to contribute 40% of global caustic soda capacity additions by 2028, amounting to 2.55 million tonnes/year between 2024-2028 through seven new build plants, two expansion projects; growth driven by textiles, soaps/detergents
Published: April 15, 2024 by GlobalData Plc

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count